Science and health for all children with cancer
Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved sur...
Uloženo v:
| Vydáno v: | Science (American Association for the Advancement of Science) Ročník 363; číslo 6432; s. 1182 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
15.03.2019
|
| Témata: | |
| ISSN: | 1095-9203, 1095-9203 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030. |
|---|---|
| AbstractList | Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030. Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030.Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with cancer in high-income countries (HICs) but are less than 30% for the 384,000 children in lower-middle-income countries (LMICs). Improved survival rates in HICs have been achieved through multidisciplinary care and research, with treatment regimens using mostly generic medicines and optimized risk stratification. Children's outcomes in LMICs can be improved through global collaborative partnerships that help local leaders adapt effective treatments to local resources and clinical needs, as well as address common problems such as delayed diagnosis and treatment abandonment. Together, these approaches may bring within reach the global survival target recently set by the World Health Organization: 60% survival for all children with cancer by 2030. |
| Author | Lam, Catherine G Pritchard-Jones, Kathy Howard, Scott C Bouffet, Eric |
| Author_xml | – sequence: 1 givenname: Catherine G orcidid: 0000-0003-1363-5331 surname: Lam fullname: Lam, Catherine G email: catherine.lam@stjude.org organization: University of Tennessee Health Sciences Center, Memphis, TN, USA – sequence: 2 givenname: Scott C orcidid: 0000-0003-2244-1686 surname: Howard fullname: Howard, Scott C organization: Board, International Society of Paediatric Oncology (SIOP), Zug, Switzerland – sequence: 3 givenname: Eric surname: Bouffet fullname: Bouffet, Eric organization: Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada – sequence: 4 givenname: Kathy orcidid: 0000-0002-2384-9475 surname: Pritchard-Jones fullname: Pritchard-Jones, Kathy organization: UCL Great Ormond Street Institute of Child Health, University College London, London, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30872518$$D View this record in MEDLINE/PubMed |
| BookMark | eNpNj0tLxDAUhYOMOA9du5Ms3XQmr6bJUgZfMOBCXZc7yQ2tpO3YtAz-ewszgqvz4OPAWZJZ27VIyC1na86F3iRXY-twDXBUxooLsuDM5pkVTM7--TlZpvTF2JStvCJzyUwhcm4WZPN-WqDQelohxKGioespxEhdVUffY0uP9dQ6mLD-mlwGiAlvzroin0-PH9uXbPf2_Lp92GVOqmLIkKtgfMh18AwRneOFL5jzU9RBF8bLXLKcWeNUvjdKogEwUnrwyCwwFCtyf9o99N33iGkomzo5jBFa7MZUCm4l18roYkLvzui4b9CXh75uoP8p_06KX4EoVkc |
| CitedBy_id | crossref_primary_10_4274_jbuch_galenos_2024_04372 crossref_primary_10_1002_nop2_1958 crossref_primary_10_1080_14737140_2021_1895756 crossref_primary_10_1186_s12887_025_05847_7 crossref_primary_10_1590_1413_81232023282_11672022en crossref_primary_10_1016_j_hmedic_2025_100283 crossref_primary_10_3390_children8121173 crossref_primary_10_1080_01635581_2022_2076888 crossref_primary_10_1007_s42399_021_00860_0 crossref_primary_10_26633_RPSP_2023_134 crossref_primary_10_1016_j_pedn_2023_02_005 crossref_primary_10_20960_nh_04369 crossref_primary_10_1177_2333794X241275258 crossref_primary_10_1002_pbc_29577 crossref_primary_10_14309_ajg_0000000000001133 crossref_primary_10_2196_66614 crossref_primary_10_1186_s12885_025_13586_2 crossref_primary_10_3390_pharmaceutics17091236 crossref_primary_10_1016_j_repbio_2024_100959 crossref_primary_10_1002_pbc_28908 crossref_primary_10_1038_s41408_022_00726_1 crossref_primary_10_1016_j_clon_2019_05_018 crossref_primary_10_1007_s40265_024_02001_y crossref_primary_10_1186_s12910_021_00597_4 crossref_primary_10_3390_curroncol32090486 crossref_primary_10_1007_s13312_023_2931_0 crossref_primary_10_1093_hropen_hoaf023 crossref_primary_10_3389_fped_2023_1223889 crossref_primary_10_32635_2176_9745_RBC_2023v69n1_3054 crossref_primary_10_1007_s00431_023_05266_9 crossref_primary_10_1016_j_pedn_2024_01_027 crossref_primary_10_1530_EC_22_0261 crossref_primary_10_1136_bmjopen_2022_070694 crossref_primary_10_1200_GO_24_00279 crossref_primary_10_1111_bjh_17959 crossref_primary_10_1097_NCC_0000000000000904 crossref_primary_10_1186_s12913_022_08188_8 crossref_primary_10_3390_children12040479 crossref_primary_10_1186_s12910_024_01075_3 crossref_primary_10_1136_bmjopen_2022_065776 crossref_primary_10_3389_fonc_2025_1620316 crossref_primary_10_1002_cam4_6925 crossref_primary_10_1097_MPH_0000000000003044 crossref_primary_10_1002_pbc_31500 crossref_primary_10_1016_S2352_4642_25_00103_8 crossref_primary_10_1038_s41598_024_60567_9 crossref_primary_10_1016_j_chemosphere_2023_139800 crossref_primary_10_3389_fphar_2022_711704 crossref_primary_10_1016_j_jpsychores_2022_110805 crossref_primary_10_1186_s12939_025_02421_6 crossref_primary_10_1016_S0140_6736_22_01541_0 crossref_primary_10_1016_S1470_2045_24_00010_X crossref_primary_10_1001_jamanetworkopen_2022_1253 crossref_primary_10_26633_RPSP_2023_148 crossref_primary_10_3389_fonc_2024_1387905 crossref_primary_10_1002_pbc_32031 crossref_primary_10_1016_j_bbrc_2025_151854 crossref_primary_10_26633_RPSP_2023_144 crossref_primary_10_1371_journal_pone_0312536 crossref_primary_10_1002_pbc_29788 crossref_primary_10_1002_pbc_30090 crossref_primary_10_1080_00325481_2022_2090184 crossref_primary_10_1371_journal_pone_0243795 crossref_primary_10_1590_1413_81232023282_11672022 crossref_primary_10_1093_nar_gkac988 crossref_primary_10_1186_s12887_025_05993_y crossref_primary_10_3390_vaccines9060653 crossref_primary_10_1016_j_phoj_2024_04_006 crossref_primary_10_1155_2023_2910350 crossref_primary_10_4102_hsag_v25i0_1382 crossref_primary_10_1002_pbc_29095 crossref_primary_10_1002_pbc_29770 crossref_primary_10_1016_j_pedn_2024_10_031 crossref_primary_10_1097_INF_0000000000002758 crossref_primary_10_1371_journal_pone_0312663 crossref_primary_10_1200_JGO_19_00161 crossref_primary_10_3389_fonc_2024_1304640 crossref_primary_10_1002_ijc_33818 crossref_primary_10_3389_fonc_2023_1044177 crossref_primary_10_1016_j_soncn_2021_151165 crossref_primary_10_1016_j_ijnurstu_2024_104891 crossref_primary_10_1002_cnr2_70203 crossref_primary_10_1002_pbc_30865 crossref_primary_10_1002_pbc_31833 crossref_primary_10_1177_27527530231190373 crossref_primary_10_2196_48799 crossref_primary_10_1038_s41416_021_01533_4 crossref_primary_10_4000_anthropologiesante_10500 crossref_primary_10_1016_j_mad_2021_111583 crossref_primary_10_1016_S1470_2045_19_30662_X crossref_primary_10_1007_s00381_024_06629_9 crossref_primary_10_1016_j_canep_2024_102685 crossref_primary_10_1002_pbc_29646 crossref_primary_10_26633_RPSP_2023_41 crossref_primary_10_1016_j_annonc_2022_03_011 crossref_primary_10_1186_s40359_023_01406_w crossref_primary_10_1002_cnr2_1576 crossref_primary_10_3389_fendo_2023_1158405 crossref_primary_10_12688_f1000research_110079_1 crossref_primary_10_1038_s41408_023_00853_3 crossref_primary_10_34133_bmr_0016 crossref_primary_10_1016_j_pedn_2024_07_005 crossref_primary_10_1016_j_ctrv_2020_102061 crossref_primary_10_1089_jayao_2022_0127 crossref_primary_10_1186_s12912_025_03273_9 crossref_primary_10_1200_GO_24_00443 crossref_primary_10_1080_15592294_2019_1633868 crossref_primary_10_1158_2159_8290_CD_23_0451 crossref_primary_10_1111_wvn_12764 crossref_primary_10_1371_journal_pone_0292794 crossref_primary_10_1136_bmjopen_2023_071988 crossref_primary_10_1002_pbc_28409 crossref_primary_10_1111_ecc_13438 crossref_primary_10_3389_fcell_2025_1558403 crossref_primary_10_1080_08880018_2022_2025963 crossref_primary_10_1177_10664807241308898 crossref_primary_10_1186_s12912_024_02483_x crossref_primary_10_1002_pbc_29186 crossref_primary_10_1002_pbc_30175 crossref_primary_10_3390_children9050651 crossref_primary_10_1007_s11764_023_01517_8 crossref_primary_10_1002_SMMD_20220008 crossref_primary_10_3389_fpubh_2022_908955 crossref_primary_10_1016_S0140_6736_24_00495_1 crossref_primary_10_1542_peds_2021_053852F crossref_primary_10_3390_pathogens9010051 crossref_primary_10_1177_27527530221121729 crossref_primary_10_3389_fonc_2023_1232451 crossref_primary_10_1186_s12916_021_01950_5 crossref_primary_10_1177_27527530231193974 crossref_primary_10_3390_ijms26094132 crossref_primary_10_1002_pbc_31245 crossref_primary_10_1016_j_eclinm_2025_103463 crossref_primary_10_11124_JBIES_22_00319 crossref_primary_10_3389_fdgth_2025_1585309 crossref_primary_10_1002_pbc_29054 crossref_primary_10_1002_pbc_30285 crossref_primary_10_1242_dev_200331 crossref_primary_10_1007_s00520_023_07690_x crossref_primary_10_1016_j_scitotenv_2023_163383 crossref_primary_10_1007_s10389_021_01517_x crossref_primary_10_4102_sajo_v6i0_234 crossref_primary_10_1186_s12889_024_21155_8 crossref_primary_10_1016_j_canep_2020_101837 crossref_primary_10_1371_journal_pone_0323483 crossref_primary_10_1007_s13312_020_1842_6 crossref_primary_10_1097_MPH_0000000000002148 crossref_primary_10_1007_s00277_022_04843_6 crossref_primary_10_3389_fonc_2023_1236942 crossref_primary_10_1016_S1470_2045_24_00559_X crossref_primary_10_1016_j_cryobiol_2023_104841 crossref_primary_10_3389_fped_2021_768438 crossref_primary_10_3390_jcm10071437 crossref_primary_10_1016_j_ejon_2022_102189 crossref_primary_10_1016_j_pedhc_2021_05_005 crossref_primary_10_12688_f1000research_112667_1 crossref_primary_10_3389_fonc_2024_1354826 crossref_primary_10_1080_14728222_2022_2166829 crossref_primary_10_1080_14737140_2024_2411255 crossref_primary_10_1002_pbc_29726 crossref_primary_10_1038_s41591_023_02221_x crossref_primary_10_1016_S2352_4642_22_00286_3 crossref_primary_10_1080_07347332_2024_2335170 crossref_primary_10_1177_27527530211056001 crossref_primary_10_1186_s12885_024_12272_z crossref_primary_10_3390_cancers15143729 crossref_primary_10_18270_rce_4666 crossref_primary_10_1002_pbc_28180 crossref_primary_10_1002_pbc_31353 crossref_primary_10_1200_GO_23_00313 crossref_primary_10_1016_j_lanepe_2025_101363 crossref_primary_10_21682_2311_1267_2024_11_4_44_50 crossref_primary_10_1186_s12885_023_10565_3 crossref_primary_10_1093_jsprm_snac024 crossref_primary_10_1016_j_eehl_2024_10_003 crossref_primary_10_1200_GO_20_00170 crossref_primary_10_1016_j_bulcan_2025_07_011 crossref_primary_10_1089_jayao_2024_0011 crossref_primary_10_1001_jamanetworkopen_2022_31182 crossref_primary_10_1016_j_isci_2024_111356 crossref_primary_10_1186_s12903_024_03938_y crossref_primary_10_1159_000530970 crossref_primary_10_1053_j_seminoncol_2020_02_006 crossref_primary_10_1200_GO_22_00156 crossref_primary_10_1200_GO_21_00049 crossref_primary_10_3390_ijerph20010443 crossref_primary_10_1039_D0SC05495J crossref_primary_10_1136_bmjopen_2024_085439 crossref_primary_10_1136_bmjgh_2022_008797 crossref_primary_10_3390_ijms23095159 crossref_primary_10_1017_S1478951522001328 crossref_primary_10_1016_j_scitotenv_2024_173328 crossref_primary_10_1002_cncr_34002 crossref_primary_10_1016_S1470_2045_21_00491_5 crossref_primary_10_3390_cancers14143295 crossref_primary_10_52560_2713_0118_2025_4_44_63 crossref_primary_10_1038_s41572_024_00542_w crossref_primary_10_1177_0272989X251314031 crossref_primary_10_1002_pbc_30484 crossref_primary_10_1200_EDBK_25_472268 crossref_primary_10_1002_pbc_29257 crossref_primary_10_3166_pson_2022_0215 crossref_primary_10_3389_fonc_2022_882501 crossref_primary_10_3390_s23031482 crossref_primary_10_1002_cai2_44 crossref_primary_10_3389_fpubh_2022_839835 crossref_primary_10_1097_CR9_0000000000000008 crossref_primary_10_1007_s00520_023_07913_1 crossref_primary_10_1136_bmjopen_2022_068210 crossref_primary_10_1590_0034_7167_2022_0193 crossref_primary_10_1002_adma_202005140 crossref_primary_10_2478_ast_2023_0011 crossref_primary_10_1016_j_jpedsurg_2025_162464 crossref_primary_10_1016_j_isci_2025_112414 crossref_primary_10_1186_s12887_025_05727_0 crossref_primary_10_1136_bmjopen_2024_085348 crossref_primary_10_1002_pbc_31669 crossref_primary_10_1186_s12887_025_05556_1 crossref_primary_10_1590_0034_7167_2022_0193pt crossref_primary_10_1016_j_jeconom_2023_105573 crossref_primary_10_1016_S0140_6736_21_02532_0 crossref_primary_10_1002_pbc_28143 crossref_primary_10_1002_pbc_29233 crossref_primary_10_1186_s12906_022_03537_w crossref_primary_10_1016_S1470_2045_20_30022_X crossref_primary_10_1055_s_0042_1748938 crossref_primary_10_1371_journal_pone_0319110 crossref_primary_10_32635_2176_9745_RBC_2023v69n1_3700 crossref_primary_10_1007_s10238_025_01707_x crossref_primary_10_1007_s00383_025_06050_6 crossref_primary_10_1136_bmjgh_2025_019345 crossref_primary_10_1038_s41568_023_00645_8 crossref_primary_10_3390_ijms25158307 crossref_primary_10_1080_07481187_2022_2142324 crossref_primary_10_1038_s41568_024_00775_7 crossref_primary_10_1038_s41572_021_00308_8 crossref_primary_10_7189_jogh_14_04104 crossref_primary_10_1002_cnr2_1849 crossref_primary_10_1111_jnu_12798 crossref_primary_10_3389_fonc_2022_869752 crossref_primary_10_1016_j_vhri_2024_101016 |
| ContentType | Journal Article |
| Copyright | Copyright © 2019, American Association for the Advancement of Science. |
| Copyright_xml | – notice: Copyright © 2019, American Association for the Advancement of Science. |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1126/science.aaw4892 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Sciences (General) Biology |
| EISSN | 1095-9203 |
| ExternalDocumentID | 30872518 |
| Genre | Journal Article Review |
| GroupedDBID | --- --Z -DZ -ET -~X .-4 ..I .55 .DC 08G 0R~ 0WA 123 18M 2FS 2KS 2WC 2XV 34G 36B 39C 3R3 53G 5RE 66. 6OB 6TJ 7X2 7~K 85S 8F7 AABCJ AACGO AAIKC AAMNW AANCE AAWTO ABBHK ABCQX ABDBF ABDEX ABDQB ABEFU ABIVO ABJNI ABOCM ABPLY ABPPZ ABQIJ ABTLG ABWJO ABZEH ACBEA ACBEC ACGFO ACGFS ACGOD ACIWK ACMJI ACNCT ACPRK ACQOY ACUHS ADDRP ADUKH ADXHL AEGBM AENEX AETEA AEUPB AEXZC AFBNE AFFDN AFFNX AFHKK AFQFN AFRAH AGNAY AGSOS AHMBA AIDAL AIDUJ AJGZS ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI ASPBG AVWKF BKF BLC C45 CGR CS3 CUY CVF DB2 DCCCD DU5 EBS ECM EIF EJD EMOBN F5P FA8 FEDTE HZ~ I.T IAO IEA IGS IH2 IHR INH INR IOF IOV IPO IPSME IPY ISE JAAYA JBMMH JCF JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST K-O KCC L7B LSO LU7 M0P MQT MVM N9A NEJ NHB NPM O9- OCB OFXIZ OGEVE OMK OVD P-O P2P PQQKQ PZZ QS- RHI RXW SA0 SC5 SJN TAE TEORI TN5 TWZ UBW UCV UHB UKR UMD UNMZH UQL USG VVN WH7 WI4 X7M XJF XZL Y6R YK4 YKV YNT YOJ YR2 YR5 YRY YSQ YV5 YWH YYP YZZ ZCA ZE2 ~02 ~G0 ~KM ~ZZ 7X8 |
| ID | FETCH-LOGICAL-c347t-e14f8df56fd0eeecc17d70cdfd06f678d35305098c45b843e8aa833dade09a0e2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 263 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000461329000039&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1095-9203 |
| IngestDate | Sun Sep 28 02:05:32 EDT 2025 Mon Jul 21 06:02:21 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6432 |
| Language | English |
| License | Copyright © 2019, American Association for the Advancement of Science. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c347t-e14f8df56fd0eeecc17d70cdfd06f678d35305098c45b843e8aa833dade09a0e2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0003-2244-1686 0000-0002-2384-9475 0000-0003-1363-5331 |
| PMID | 30872518 |
| PQID | 2193164867 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2193164867 pubmed_primary_30872518 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-03-15 |
| PublicationDateYYYYMMDD | 2019-03-15 |
| PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-15 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Science (American Association for the Advancement of Science) |
| PublicationTitleAlternate | Science |
| PublicationYear | 2019 |
| SSID | ssj0009593 |
| Score | 2.6738725 |
| SecondaryResourceType | review_article |
| Snippet | Each year ~429,000 children and adolescents aged 0 to 19 years are expected to develop cancer. Five-year survival rates exceed 80% for the 45,000 children with... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 1182 |
| SubjectTerms | Adolescent Adult Child Child, Preschool Delayed Diagnosis - adverse effects Developed Countries - statistics & numerical data Developing Countries - statistics & numerical data Drug Development Global Health Health Resources Health Services Accessibility Humans Incidence Infant Infant, Newborn Neoplasms - diagnosis Neoplasms - mortality Neoplasms - therapy World Health Organization Young Adult |
| Title | Science and health for all children with cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/30872518 https://www.proquest.com/docview/2193164867 |
| Volume | 363 |
| WOSCitedRecordID | wos000461329000039&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB7UKnhRW1_1xQoe9BC7yW6azUlELB609KDSW9jsAwolrU1V_PfOJlsUQRC8BBJYCLPz-HZ25huAs8hiGNXcBDZleEBJI4E2J5NAU2XTkCkRV0U0z_dJvy-Gw3TgE26lL6tc-MTKUeuJcjnyDloWQ2gvusnV9CVwU6Pc7aofobEMDYZQxpV0JUPxk3Q3pG4eYUSZp_b51jRzKeU7F9U96C_4soozvc3__uEWbHiESa5rlWjCkilasFbPnPxoQdNbc0nOPeX0xTZ0_EciC03q1kiCaJbI8Zgs2r2JS9kS5bRktgNPvdvHm7vAj1IIFOPJPDAht0LjvlhNjcFtCxOdUKXxtWsxXmkWM8cEIxSPc8GZEVIKxrTUhqaSmmgXVopJYfaB4HnQgQxOLbW8q1kueYxuQueIFEIr8jacLsSToaq6-wdZmMlrmX0JqA17tYyzac2pkTliQoRa4uAPqw9hHWFL6irBwvgIGhYN1RzDqnqbj8rZSaUD-OwPHj4Bqeu6lA |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Science+and+health+for+all+children+with+cancer&rft.jtitle=Science+%28American+Association+for+the+Advancement+of+Science%29&rft.au=Lam%2C+Catherine+G&rft.au=Howard%2C+Scott+C&rft.au=Bouffet%2C+Eric&rft.au=Pritchard-Jones%2C+Kathy&rft.date=2019-03-15&rft.eissn=1095-9203&rft.volume=363&rft.issue=6432&rft.spage=1182&rft_id=info:doi/10.1126%2Fscience.aaw4892&rft_id=info%3Apmid%2F30872518&rft_id=info%3Apmid%2F30872518&rft.externalDocID=30872518 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1095-9203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1095-9203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1095-9203&client=summon |